======= CSTF3 =======
== Gene Information ==
* **Official Symbol**: CSTF3
* **Official Name**: cleavage stimulation factor subunit 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1479|1479]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q12996|Q12996]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CSTF3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CSTF3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600367|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: One of the multiple factors required for polyadenylation and 3'-end cleavage of mammalian pre-mRNAs.
|Suf|
|mRNA cleavage|
|mRNA polyadenylation|
|RNA polyadenylation|
|termination of RNA polymerase II transcription|
|DNA-templated transcription, termination|
|mRNA 3-end processing|
|RNA 3-end processing|
|RNA phosphodiester bond hydrolysis|
|mRNA binding|
|mRNA splicing, via spliceosome|
|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|
|nucleic acid phosphodiester bond hydrolysis|
|RNA splicing, via transesterification reactions|
|RNA splicing|
|mRNA processing|
|transcription by RNA polymerase II|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|mRNA metabolic process|
|RNA processing|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|RNA binding|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|1.71|
|[[:results:exp285|GW501516 25μM R06 exp285]]|1.73|
|[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.74|
|[[:results:exp372|Ibrutinib 1μM R07 exp372]]|1.76|
|[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|1.84|
|[[:results:exp279|D-Fructose 10000μM R06 exp279]]|1.85|
|[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|1.88|
|[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|1.89|
|[[:results:exp391|Pomalidomide 20μM R07 exp391]]|2.05|
|[[:results:exp134|MS023 2μM R03 exp134]]|2.3|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 324/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|0/1|
|bile duct|14/28|
|blood|13/28|
|bone|18/25|
|breast|15/33|
|central nervous system|24/56|
|cervix|1/4|
|colorectal|3/17|
|esophagus|7/13|
|fibroblast|0/1|
|gastric|2/15|
|kidney|12/21|
|liver|8/20|
|lung|35/75|
|lymphocyte|10/14|
|ovary|15/26|
|pancreas|10/24|
|peripheral nervous system|10/16|
|plasma cell|8/15|
|prostate|0/1|
|skin|16/24|
|soft tissue|2/7|
|thyroid|1/2|
|upper aerodigestive|7/22|
|urinary tract|15/29|
|uterus|2/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 591
* **Expression level (log2 read counts)**: 5.92
{{:chemogenomics:nalm6 dist.png?nolink |}}